Published in Am J Transplant on September 18, 2013
Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates. Am J Transplant (2014) 1.44
CD57(+) CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection. Am J Transplant (2016) 1.09
Isolated endarteritis and kidney transplant survival: a multicenter collaborative study. J Am Soc Nephrol (2014) 0.94
Tolerance in organ transplantation: from conventional immunosuppression to extracellular vesicles. Front Immunol (2014) 0.88
Transplantation tolerance: from theory to clinic. Immunol Rev (2014) 0.88
What's new in clinical solid organ transplantation by 2013. World J Transplant (2014) 0.81
Costimulation Blockade in Autoimmunity and Transplantation: The CD28 Pathway. J Immunol (2016) 0.80
Vascular endothelium as a target of immune response in renal transplant rejection. Front Immunol (2014) 0.80
A pilot trial targeting the ICOS-ICOS-L pathway in nonhuman primate kidney transplantation. Am J Transplant (2015) 0.80
Report from IPITA-TTS Opinion Leaders Meeting on the Future of β-Cell Replacement. Transplantation (2016) 0.79
Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy. Immunol Rev (2017) 0.78
Minimization vs tailoring: Where do we stand with personalized immunosuppression during renal transplantation in 2015? World J Transplant (2015) 0.78
Impact of Immune-Modulatory Drugs on Regulatory T Cell. Transplantation (2016) 0.77
Metabolic consequences of modern immunosuppressive agents in solid organ transplantation. Ther Adv Endocrinol Metab (2016) 0.77
Dysglycemia after renal transplantation: Definition, pathogenesis, outcomes and implications for management. World J Diabetes (2015) 0.76
Delayed Cytotoxic T Lymphocyte-Associated Protein 4-Immunoglobulin Treatment Reverses Ongoing Alloantibody Responses and Rescues Allografts From Acute Rejection. Am J Transplant (2016) 0.76
Beneficial effect of conversion to belatacept in kidney-transplant patients with a low glomerular-filtration rate. Case Rep Transplant (2014) 0.75
Old game, new players: Linking classical theories to new trends in transplant immunology. World J Transplant (2017) 0.75
Preemptive CD20+ B cell Depletion Attenuates Cardiac Allograft Vasculopathy in CD154-Treated Monkeys. Transplantation (2016) 0.75
Transplantation: BENEFIT of belatacept: kidney transplantation moves forward. Nat Rev Nephrol (2016) 0.75
Belatacept conversion in African American kidney transplant recipients with severe renal dysfunction. SAGE Open Med Case Rep (2016) 0.75
Belatacept for the prophylaxis of organ rejection in kidney transplant patients: an evidence-based review of its place in therapy. Int J Nephrol Renovasc Dis (2016) 0.75
Tacrolimus to Belatacept Conversion Following Hand Transplantation: A Case Report. Am J Transplant (2015) 0.75
Immunological aspects of liver cell transplantation. World J Transplant (2016) 0.75
A systems-based approach to managing blood pressure in children following kidney transplantation. Pediatr Nephrol (2015) 0.75
Role of Memory T Cells in Allograft Rejection and Tolerance. Front Immunol (2017) 0.75
Soluble co-signaling molecules predict long-term graft outcome in kidney-transplanted patients. PLoS One (2014) 0.75
Belatacept Resistant Rejection is Associated with CD28(+) Memory CD8 T cells. Am J Transplant (2017) 0.75
Successful Treatment of T Cell-Mediated Acute Rejection with Delayed CTLA4-Ig in Mice. Front Immunol (2017) 0.75
Compilation of tRNA sequences and sequences of tRNA genes. Nucleic Acids Res (1998) 10.74
A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant (2010) 5.40
Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N Engl J Med (1996) 4.41
Compilation of tRNA sequences and sequences of tRNA genes. Nucleic Acids Res (1996) 4.31
Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med (1995) 3.92
The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am J Transplant (2010) 3.35
4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J Exp Med (1997) 3.31
Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J Exp Med (1995) 3.16
A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study). Am J Transplant (2010) 3.05
Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer. J Clin Oncol (1992) 3.00
Tolerance versus immunosuppression: a perspective. Am J Transplant (2008) 2.71
Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med (1989) 2.69
Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study. Am J Transplant (2007) 2.46
A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group. Transplantation (1997) 2.46
Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression. Am J Transplant (2010) 2.37
Transplantation tolerance induced by CTLA4-Ig. Transplantation (1994) 2.36
Antibody to Varicella-Zoster virus in parturient women and their offspring during the first year of life. Pediatrics (1976) 2.35
Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry (2009) 2.29
Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest (1999) 2.26
Breast-conserving therapy vs mastectomy in early-stage breast cancer: a meta-analysis of 10-year survival. Cancer J Sci Am (1997) 2.09
Transmission of varicella-vaccine virus from a healthy 12-month-old child to his pregnant mother. J Pediatr (1997) 2.00
Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory. J Immunol (2001) 1.96
Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group. J Pediatr (1992) 1.94
Three-year outcomes from BENEFIT, a randomized, active-controlled, parallel-group study in adult kidney transplant recipients. Am J Transplant (2011) 1.93
The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients. Am J Transplant (2011) 1.90
Posttranscriptionally modified nucleosides in transfer RNA: their locations and frequencies. Biochimie (1995) 1.90
Calcineurin inhibitor minimization in the Symphony study: observational results 3 years after transplantation. Am J Transplant (2009) 1.88
Detection of antibody to Varicella-Zoster virus by immune adherence hemagglutination. Proc Soc Exp Biol Med (1976) 1.88
IFN-gamma is critical for long-term allograft survival induced by blocking the CD28 and CD40 ligand T cell costimulation pathways. J Immunol (1998) 1.86
Effects of the renin-angiotensin system on the current I(to) in epicardial and endocardial ventricular myocytes from the canine heart. Circ Res (2000) 1.81
Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth. Aliment Pharmacol Ther (2005) 1.78
The natural history of chronic hepatitis C in haemophiliacs. Br J Haematol (1996) 1.76
Efficacy and safety of sodium phosphate tablets compared with PEG solution in colon cleansing: two identically designed, randomized, controlled, parallel group, multicenter phase III trials. Gastrointest Endosc (2001) 1.75
Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors. Am J Transplant (2014) 1.70
Sotrastaurin, a novel small molecule inhibiting protein-kinase C: randomized phase II study in renal transplant recipients. Am J Transplant (2011) 1.69
A mouse model for polyomavirus-associated nephropathy of kidney transplants. Am J Transplant (2006) 1.65
4-1BB ligand, a member of the TNF family, is important for the generation of antiviral CD8 T cell responses. J Immunol (1999) 1.63
Cytokine gene transcription in vascularised organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med (1991) 1.62
Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology (1995) 1.60
Zoster immune globulin. A further assessment. N Engl J Med (1974) 1.57
Evidence for kidney rejection after combined bone marrow and renal transplantation despite ongoing whole-blood chimerism in rhesus macaques. Am J Transplant (2012) 1.54
Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg (1988) 1.54
Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients. Clin Cancer Res (1999) 1.54
Microchimerism and rejection in clinical transplantation. Lancet (1997) 1.53
Epidemiology of HIV/AIDS in children. Pediatr Clin North Am (2000) 1.53
Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplant. Am J Transplant (2011) 1.51
Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer. Am J Transplant (2014) 1.50
The gut origin septic states in blunt multiple trauma (ISS = 40) in the ICU. Ann Surg (1987) 1.50
Characterization of virus-mediated inhibition of mixed chimerism and allospecific tolerance. J Immunol (2001) 1.49
Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation. Am J Transplant (2010) 1.48
Varicella-Zoster Immunoglobulins during Varicella, Latency, and Zoster. J Infect Dis (1975) 1.47
Costimulation blockade, busulfan, and bone marrow promote titratable macrochimerism, induce transplantation tolerance, and correct genetic hemoglobinopathies with minimal myelosuppression. J Immunol (2001) 1.46
Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancer. J Clin Oncol (1989) 1.46
Varicella-zoster-associated encephalitis: detection of specific antibody in cerebrospinal fluid. J Clin Microbiol (1980) 1.45
Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg (1980) 1.45
A ten year experience with cadaver kidney preservation using cryoprecipitated plasma. Am J Surg (1978) 1.44
Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. J Immunol (2000) 1.43
The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors. Transplantation (1995) 1.43
Polyomavirus BK replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: a prospective, randomized, multicenter study. Am J Transplant (2012) 1.42
Detrimental effects of ocean acidification on the economically important Mediterranean red coral (Corallium rubrum). Glob Chang Biol (2013) 1.41
Isolation and characterization of dendritic cells from mouse heart and kidney. J Immunol (1994) 1.40
Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders. J Cell Sci (1995) 1.40
A mental health fellowship program in an HMO setting. Hosp Community Psychiatry (1991) 1.39
FasL is important in costimulation blockade-resistant skin graft rejection. Transplantation (2001) 1.39
A neutron reflectivity study of polymer-modified phospholipid monolayers at the solid-solution interface: polyethylene glycol-lipids on silane-modified substrates. Biophys J (1998) 1.38
Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation. Transplantation (1998) 1.36
Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tarolimus versus cyclosporine: a report of the FK506 Kidney Transplant Study Group. Transplantation (1998) 1.35
Varicella vaccine: the American experience. J Infect Dis (1992) 1.35
Immune selection after antigen-specific immunotherapy of melanoma. Surgery (1999) 1.34
The effect of costimulatory and interleukin 2 receptor blockade on regulatory T cells in renal transplantation. Am J Transplant (2008) 1.33
Immunosuppression with belatacept-based, corticosteroid-avoiding regimens in de novo kidney transplant recipients. Am J Transplant (2010) 1.31
Induction of chimerism in rhesus macaques through stem cell transplant and costimulation blockade-based immunosuppression. Am J Transplant (2007) 1.30
CD40-CD40 ligand costimulation is required for generating antiviral CD4 T cell responses but is dispensable for CD8 T cell responses. J Immunol (1999) 1.28
Transplant tolerance in non-human primates: progress, current challenges and unmet needs. Am J Transplant (2006) 1.27
An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group. Transplantation (1996) 1.27
Recurrent and de novo glomerular disease after renal transplantation: a report from Renal Allograft Disease Registry (RADR). Transplantation (1999) 1.27
Recurrent focal glomerulosclerosis: natural history and response to therapy. Am J Med (1992) 1.24
Polymerase chain reaction and restriction fragment length polymorphism analysis of varicella-zoster virus isolates from the United States and other parts of the world. J Infect Dis (1998) 1.24
Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts. J Immunol (2000) 1.23
A high-density YAC contig map of human chromosome 22. Nature (1995) 1.23
Sirolimus enhances the magnitude and quality of viral-specific CD8+ T-cell responses to vaccinia virus vaccination in rhesus macaques. Am J Transplant (2011) 1.23
Psychosocial outcome after ICD implantation: a current perspective. Pacing Clin Electrophysiol (1998) 1.21
4-1BB costimulation is required for protective anti-viral immunity after peptide vaccination. J Immunol (2000) 1.21
Cytokine gene expression: analysis using northern blotting, polymerase chain reaction and in situ hybridization. Immunol Rev (1991) 1.21
CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates. Am J Transplant (2011) 1.19
CD40 blockade combines with CTLA4Ig and sirolimus to produce mixed chimerism in an MHC-defined rhesus macaque transplant model. Am J Transplant (2011) 1.18
ABO genotype and risk of thrombotic events and hemorrhagic stroke. J Thromb Haemost (2008) 1.18
Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am J Kidney Dis (1994) 1.18
Engraftment of adult porcine islet xenografts in diabetic nonhuman primates through targeting of costimulation pathways. Am J Transplant (2007) 1.17
Miles to go…. Am J Transplant (2011) 1.17
A seven-year experience with donor-specific blood transfusions. Results and considerations for maximum efficacy. Transplantation (1985) 1.17
Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4. J Immunol (1997) 1.16